Nostrum Pharmaceuticals LLC
http://www.nostrumpharma.com/
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From Nostrum Pharmaceuticals LLC
Novartis MS Franchise Boosted After Fending Off Last Gilenya Challenge
The Swiss firm expects no generic versions of Gilenya in the US market "for at least the next two years" after a court again ruled against HEC Pharma, the only remaining company challenging its patent.
Deal Watch: AbbVie Bets On Turnstone’s Cancer Immunotherapy Technology
AbbVie takes options on three oncolytic virus immunotherapies under development at Turnstone. Amgen and CytomX swap IP in cancer immunotherapy collaboration, while Nicox and pSivida will team to fight glaucoma and other eye diseases.
Sun Still Prowling For Acquisitions As It Sells Two US Plants
India's Sun Pharmaceutical Industries has said it is seeking "well-managed" acquisition targets -- unlike its 2015 purchase of troubled rival Ranbaxy which continues to absorb “significant” management time – at the same time as pressing ahead with its consolidation drive with the disposal of two US plants.
Sun Sells US Plant As It Tackles Post-Ranbaxy Consolidation
India's Sun Pharma has clinched a deal to sell a US plant as part of a consolidation drive in the wake of its purchase of rival Ranbaxy, amid improving investor sentiment toward the country's biggest drug company.
Company Information
- Industry
- Biotechnology
- Medical Devices
- Pharmaceuticals
-
Pharmaceuticals
- Generic Drugs
- Specialty Pharmaceuticals
-
Drug Delivery
- Controlled Release
-
Biotechnology
- Large Molecule
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice